Reply
Tommy Ivanics, Marco PAW Claasen, Madhukar S. Patel, Bettina E. Hansen, Gonzalo Sapisochin – 17 April 2022
Intraoperative risk factors of acute kidney injury following liver transplantation
Rachel J. Berkowitz, Milo C. Engoren, Graciela Mentz, Pratima Sharma, Sathish S. Kumar, Ryan Davis, Sachin Kheterpal, Christopher J. Sonnenday, Nicholas J. Douville – 16 April 2022
Alcohol use disorder in community management of chronic liver diseases
Lorenzo Leggio, Jessica L. Mellinger – 16 April 2022 – Rising rates of alcohol use disorder (AUD) combined with increases in alcohol‐related liver disease (ALD) and other liver disease have resulted in the need to develop alcohol management strategies at all levels of patient care. For those with pre‐existing liver disease, whether ALD or others, attention to alcohol use treatment and abstinence becomes critical to avoiding worsening liver‐related consequences.
Letter to the editor: Cautious use of multistate modeling in prognosis analysis of HCC
Shi‐Tao Jiang, Jun‐Wei Zhang, Xin Lu, Yi‐Yao Xu – 16 April 2022
Erratum
16 April 2022
Prophylactic embolization of large spontaneous portosystemic shunts with transjugular intrahepatic portosystemic shunt (TIPS): A panacea for post‐TIPS hepatic encephalopathy?
Dhiraj Tripathi, Christophe Bureau – 15 April 2022
Reply
Alexander S. Vogel, Gene Y. Im – 15 April 2022
Coronavirus disease 2019 (COVID‐19) vaccination in patients with cirrhosis: Does it work?
Alberto Calleri, Margherita Saracco, Renato Romagnoli, Silvia Martini – 15 April 2022
Portal fibroblasts: A renewable source of liver myofibroblasts
Steven P. O’Hara, Nicholas F. LaRusso – 15 April 2022
Standardizing the histological assessment of late posttransplantation biopsies from pediatric liver allograft recipients
Stefan G. Hübscher, Sandy Feng, Annette S. H. Gouw, Hironori Haga, Hyo Jeong Kang, Deirdre A. Kelly, Mina Komuta, Andrew Lesniak, Benjamin A. Popp, Henkjan J. Verkade, Eunsil Yu, Anthony J. Demetris – 15 April 2022 – Excellent short‐term survival after pediatric liver transplantation (LT) has shifted attention toward the optimization of long‐term outcomes. Despite considerable progress in imaging and other noninvasive modalities, liver biopsies continue to be required to monitor allograft health and to titrate immunosuppression.